OTCQX:MRVFF - Post by User
Post by
rogerouton Apr 27, 2007 10:58am
206 Views
Post# 12685963
FDA Rejects Merck''s Vioxx Successor
FDA Rejects Merck''s Vioxx SuccessorArcoxia had been poised for approval until Vioxx was pulled from the market. Two months later, the FDA issued what's called an "approvable" letter, saying it could approve Arcoxia, but only if Merck provided further safety and efficacy information for the drug.
Merck has since produced results from further studies of Arcoxia, but doctors questioned those results because Merck compared Arcoxia in its tests to another painkiller that has elevated risk of heart attacks and strokes.